Compliance with yellow fever and measles vaccines in the revaccination program post-hematopoietic cell transplantation

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
TESTA, Lucia H. de Almeida H.
SIMIONE, Anderson J.
SANTOS, Ana Claudia F. dos
COLTURATO, Iago
BARBIERI, Fernanda
SOUZA, Mair Pedro de
COLTURATO, Vergilio R.
Citação
TRANSPLANT INFECTIOUS DISEASE, v.25, n.4, article ID e14098, 6p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Measles, mumps, rubella, and even poliomyelitis outbreaks have recently perplexed infectious disease clinicians and epidemiologists globally due to the decline in vaccination coverage rates in children and adults. Measles and yellow fever (YF) have represented an increasing burden on the Brazilian public health system in recent decades. Both diseases are preventable by live-attenuated viral vaccines (LAVV), which have restricted use in hematopoietic cell transplant (HCT) recipients.Methods: Autologous and allogeneic HCT recipients returning for regular appointments at the outpatient clinic were invited to participate in the study. Patients transplanted for at least 2 years and with a printed copy of the vaccination record were included.Results: We assessed the vaccination records of 273 HCT recipients after the second year of HCT (193 allogeneic and 80 autologous) and observed lower compliance with the YF vaccine (58 patients, 21.2%) than with the measles vaccine (138 patients, 50.5%, p = .0001). This is the largest published series of YF vaccination in HCT recipients so far. No severe adverse events occurred. Although expected, chronic graft-versus-host disease (GVHD) did not affect the compliance with measles (p = .08) or YF vaccination (p = .7). Indeed, more allogeneic recipients received measles vaccine in comparison with autologous patients (p < .0001), suggesting that chronic GVHD was not the main reason for not being vaccinated. Children and allogeneic HCT were more likely to receive measles vaccine. Time elapsed from HCT >5 years favored both measles and YF vaccination.Conclusion: A better understanding of the reasons for low compliance with LAVV is necessary to overcome this problem.
Palavras-chave
compliance, HCT, live-attenuated vaccine, measles, vaccination, yellow fever
URI
https://observatorio.fm.usp.br/handle/OPI/58889
Referências
  1. Adler M, 2018, J INFECT DIS, V217, P1844, DOI 10.1093/infdis/jiy050
  2. Alexander KE, 2018, VACCINE, V36, P3890, DOI 10.1016/j.vaccine.2018.05.078
  3. [Anonymous], 2020, MEASL RUB CONG RUB S
  4. [Anonymous], EP UPD YELL FEV 6 MA
  5. Ariza-Heredia EJ, 2014, TRANSPL INFECT DIS, V16, P878, DOI 10.1111/tid.12312
  6. Avelino-Silva VI, 2016, HUM VACC IMMUNOTHER, V12, P937, DOI 10.1080/21645515.2015.1112475
  7. Bhalla P, 2015, CLIN INFECT DIS, V60, P1068, DOI 10.1093/cid/ciu970
  8. Cordonnier C, 2019, LANCET INFECT DIS, V19, pE200, DOI 10.1016/S1473-3099(18)30600-5
  9. Croce E, 2017, VACCINE, V35, P1216, DOI 10.1016/j.vaccine.2017.01.048
  10. da Silva PM., 2017, REV INST MED TROP SP, V59, P87
  11. de Fontbrune FS, 2018, J INFECT DIS, V217, P494, DOI 10.1093/infdis/jix564
  12. Gouveia-Alves F, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12903
  13. Hayakawa K, 2015, INT J INFECT DIS, V37, P9, DOI 10.1016/j.ijid.2015.05.025
  14. Hudspeth MP, 2010, PEDIATR BLOOD CANCER, V54, P970, DOI 10.1002/pbc.22444
  15. Ishak R, 2020, HUM VACC IMMUNOTHER, V16, P900, DOI 10.1080/21645515.2019.1678359
  16. Lerchenfeldt SM, 2013, TRANSPL INFECT DIS, V15, P634, DOI 10.1111/tid.12110
  17. Lin RY, 2023, TRANSPL INFECT DIS, V25, DOI 10.1111/tid.14043
  18. LJUNGMAN P, 1989, J INFECT DIS, V159, P610, DOI 10.1093/infdis/159.4.610
  19. Machado CM, 2009, REV INST MED TROP SP, V51, P309, DOI 10.1590/S0036-46652009000600002
  20. Machado CM, 2005, BONE MARROW TRANSPL, V35, P787, DOI 10.1038/sj.bmt.1704878
  21. Minist?rio da Sa?de, 2023, CAL NAC VAC
  22. Porudominsky R, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.75, 10.26633/rpsp.2018.75]
  23. Sabaini PMD, 2023, TRANSPL INFECT DIS, V25, DOI 10.1111/tid.14044
  24. Sato APS, 2023, CIENC SAUDE COLETIVA, V28, P351, DOI [10.1590/1413-81232023282.19172022EN, 10.1590/1413-81232023282.19172022]

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP